Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Clinical trial NCT00218543 · COMPLETED

Trial details

NCT number: NCT00218543
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity Cocaine-Related Disorders

Start date: 2004-06-01
Primary completion: 2007-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.